Thomas Vanassche (T Vanassche)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Oral Anticoagulants

Ejection Fraction

Top Venues

Dermatology and therapy

Acta clinica Belgica

Research and practice in thrombosis and haemostasis

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Tom M Hillary, Tine Vanhoutvin, Miet Peeters, Maya Imbrechts, Thomas Vanassche, Marjan Garmyn, Severine Vermeire
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State. Dermatology and therapy 14 (3) (2024)
Tom M Hillary, Tine Vanhoutvin, Miet Peeters, Maya Imbrechts, Thomas Vanassche, Marjan Garmyn, Severine Vermeire
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State. Dermatology and therapy 14 (3) (2024)
Tom M Hillary, Tine Vanhoutvin, Miet Peeters, Maya Imbrechts, Thomas Vanassche, Marjan Garmyn, Severine Vermeire
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State. Dermatology and therapy 14 (3) (2024)
Tom M Hillary, Tine Vanhoutvin, Miet Peeters, Maya Imbrechts, Thomas Vanassche, Marjan Garmyn, Severine Vermeire
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State. Dermatology and therapy 14 (3) (2024)
Tom M Hillary, Tine Vanhoutvin, Miet Peeters, Maya Imbrechts, Thomas Vanassche, Marjan Garmyn, Severine Vermeire
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State. Dermatology and therapy (2024)
Tom M Hillary, Tine Vanhoutvin, Miet Peeters, Maya Imbrechts, Thomas Vanassche, Marjan Garmyn, Severine Vermeire
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State. Dermatology and therapy 14 (3) (2024)
Matthias M Engelen, Johan Vandesande, Johan De Bent, Christine Van Laer, Veerle Labarque, Marc Jacquemin, Kathelijne Peerlinck, Cedric Hermans, Peter Verhamme, Thomas Vanassche
Emicizumab for acquired haemophilia A: A case series. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Dong-Mei Wei, Jesús D Melgarejo, Lucas Van Aelst, Thomas Vanassche, Peter Verhamme, Stefan P Janssens, Karlheinz Peter, Zhen-Yu Zhang
Prediction of Coronary Artery Disease Using Urinary Proteomics. European journal of preventive cardiology (2023)
Caroline P Martens, Marijke Peetermans, Thomas Vanassche, Peter Verhamme, Marc G Jacquemin, Kimberly Martinod
Peptidylarginine deiminase 4 and ADAMTS13 activity in Staphylococcus aureus bacteraemia. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 378 (1890) (2023)
Angela Elma Edwina, Nada Dia, Erwin Dreesen, Thomas Vanassche, Peter Verhamme, Isabel Spriet, Lorenz Roger Van der Linden, Jos Tournoy
Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative Review. Clinical pharmacokinetics (2023)
Thomas Vanassche, Matthias M Engelen, Christelle Orlando, Kristel Vandenbosch, Alain Gadisseur, Cedric Hermans, Kristin Jochmans, Jean-Marc Minon, Serge Motte, Harlinde Peperstraete, Pierre Péters, Muriel G Sprynger, Patrizio Lancellotti, Isabelle Dehaene, Patrick Emonts, Christophe Vandenbriele, Peter Verhamme, Cécile Oury
The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients. Acta clinica Belgica (2023)
Lorenz Van der Linden, Julie Hias, Thomas Vanassche
The value and limitations of new oral anticoagulant plasma level assessments. European heart journal supplements : journal of the European Society of Cardiology 24 (Suppl A) (2022)
Matthias M Engelen, Quentin Van Thillo, Albrecht Betrains, Iwein Gyselinck, Caroline P Martens, Valérie Spalart, Anna Ockerman, Caroline Devooght, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, Philippe Meersseman, Greet Van den Berghe, Dieter Dauwe, Ann Belmans, Michiel Thomeer, Tom Fivez, Dieter Mesotten, David Ruttens, Luc Heytens, Ilse Dapper, Sebastiaan Tuyls, Brecht De Tavernier, Peter Verhamme, Thomas Vanassche, null null
Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study. Research and practice in thrombosis and haemostasis 6 (7) (2022)
Pieter Martens, Chantal Mathieu, Thomas Vanassche
The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice. Acta cardiologica (2022)
Matthias M Engelen, Christophe Vandenbriele, Valérie Spalart, Caroline P Martens, Bert Vandenberk, Pieter Sinonquel, Natalie Lorent, Paul De Munter, Rik Willems, Joost Wauters, Alexander Wilmer, Dieter Frans Dauwe, Jan Gunst, Ipek Guler, Stefan P Janssens, Kimberly Martinod, Griet Pieters, Kathelijne Peerlinck, Peter Verhamme, Thomas Vanassche
Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing. Research and practice in thrombosis and haemostasis 6 (3) (2022)
Michiel Happaerts, Thomas Vanassche
Acquired hemophilia following COVID-19 vaccination: Case report and review of literature. Research and practice in thrombosis and haemostasis 6 (6) (2022)
Jesús D Melgarejo, Jan V Eijgen, Gladys E Maestre, Lama A Al-Aswad, Lutgarde Thijs, Luis J Mena, Joseph H Lee, Joseph D Terwilliger, Michele Petitto, Carlos A Chávez, Miguel Brito, Gustavo Calmon, Egle Silva, Dong-Mei Wei, Ella Cutsforth, Karel V Keer, C Gustavo De Moraes, Thomas Vanassche, Stefan P Janssens, Ingeborg Stalmans, Peter Verhamme, Jan A Staessen, Zhen-Yu Zhang
Open-Angle Glaucomatous Optic Neuropathy Is Related to Dips Rather Than Increases in the Mean Arterial Pressure Over 24-H. American journal of hypertension 35 (8) (2022)
John William Eikelboom, Jacqueline Bosch, Stuart J Connolly, Jessica Tyrwitt, Keith A A Fox, Eva Muehlhofer, Christoph Neumann, Christoph Tasto, Shrikant I Bangdiwala, Rafael Diaz, Marco Alings, Gilles R Dagenais, Darryl P Leong, Eva M Lonn, Alvaro Avezum, Leopoldo Soares Piegas, Petr Widimsky, Alexander N Parkhomenko, Deepak L Bhatt, Kelley R H Branch, Jeffrey L Probstfield, Patricio Lopez-Jaramillo, Lars Rydén, Nana Pogosova, Katalin Keltai, Matyas Keltai, Georg Ertl, Stefan Stoerk, Antonio L Dans, Fernando Tomás Lanas Zanetti, Yan Liang, Jun Zhu, Christian Torp-Pedersen, Aldo Pietro Maggioni, Patrick J Commerford, Tomasz J Guzik, Thomas Vanassche, Peter Verhamme, Martin O'Donnell, Andrew M Tonkin, John D Varigos, Dragos Vinereanu, Camillo Felix, Jae-Hyung Kim, Khairul S Ibrahim, Basil S Lewis, Kaj P Metsarinne, Victor Aboyans, Phillippe Gabriel Steg, Masatsugu Hori, Ajay Kakkar, Sonia S Anand, Andre Lamy, Mukul Sharma, Salim Yusuf
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. European heart journal. Cardiovascular pharmacotherapy 8 (8) (2022)
Tom M Hillary, Jolien Clijmans, Severine Vermeire, Jo Lambert, Marjan Garmyn, Maya Imbrechts, Thomas Vanassche
Venous thrombotic events in psoriasis patients: a systematic review with meta-analysis. Annals of medicine 53 (1) (2021)
Tim A C de Vries, Martin E W Hemels, Frank Cools, Harry J G M Crijns, Laetitia Yperzeele, Peter Vanacker, Ivan Blankoff, Patrizio Lancellotti, Georges H Mairesse, Anne de Veer, Ruben Casado Arroyo, Emmanuel Catez, Michel de Pauw, Thomas Vanassche, Carlos De Asmundis, Paulus F Kirchhof, Raffaele De Caterina, Joris R de Groot, null null
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study. Acta cardiologica 76 (4) (2021)
Lutgarde Thijs, Kei Asayama, Gladys E Maestre, Tine Willum Hansen, Luk Buyse, Dong-Mei Wei, Jesús D Melgarejo, Jana Brguljan-Hitij, Babangida S Chori, Fábio de Souza, Milosz J Jaguszewski, Kalina Kawecka-Jaszcz, Catharina Martha Cornelia Mels, Gontse Mokwatsi, Elisabeth S Muxfeldt, Alistair S Hall, Augustine N Odili, Marek W Rajzer, Aletta Elisabeth Schutte, Katarzyna Stolarz-Skrzypek, Yi-Wen Tsai, Thomas Vanassche, Raymond C Vanholder, Zhen-Yu Zhang, Peter Verhamme, Ruan Kruger, Harald Mischak, Jan A Staessen, null null, null null, null null, null null, null null
Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial: rational and protocol. Blood pressure 30 (5) (2021)
Thomas Vanassche, Peter Verhamme, Sonia S Anand, Olga Shestakovska, Darryl P Leong, Keith A A Fox, Deepak L Bhatt, Álvaro Avezum, Marco Alings, Victor Aboyans, Aldo P Maggioni, Petr Widimsky, Eva Muehlhofer, Scott D Berkowitz, Salim Yusuf, Stuart J Connolly, John William Eikelboom, Jacqueline Bosch
Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial. European heart journal. Cardiovascular pharmacotherapy (2021)
Anna Ockerman, Isabel Miclotte, Maarten Vanhaverbeke, Thomas Vanassche, Ann Belmans, Jan Vanhove, Joeri Meyns, Nasser Nadjmi, Geert Van Hemelen, Patrick Winderickx, Reinhilde Jacobs, Constantinus Politis, Peter Verhamme
Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial. PLoS medicine 18 (5) (2021)
Laurens Liesenborghs, Severien Meyers, Thomas Vanassche, Peter Verhamme
Coagulation: At the heart of infective endocarditis. Journal of thrombosis and haemostasis : JTH 18 (5) (2020)
Thomas Vanassche, M M Engelen, Q Van Thillo, J Wauters, J Gunst, C Wouters, C Vandenbriele, S Rex, L Liesenborghs, A Wilmer, P Meersseman, G Van den Berghe, D Dauwe, G Verbeke, M Thomeer, T Fivez, D Mesotten, D Ruttens, L Heytens, I Dapper, S Tuyls, B De Tavernier, P Verhamme, null null
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study. Trials 21 (1) (2020)
Thomas Vanassche, Christelle Orlando, Kristel Vandenbosch, Alain Gadisseur, Cédric Hermans, Kristin Jochmans, Jean-Marc Minon, Serge Motte, Harlinde Peperstraete, Pierre Péters, Muriel G Sprynger, Patrizio Lancellotti, Isabelle Dehaene, Patrick Emonts, Christophe Vandenbriele, Peter Verhamme, Cécile Oury
Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19. Acta clinica Belgica (2020)
Sara Akalay, Thomas Vanassche, Paul De Munter
Tigecycline-induced life-threatening coagulopathy in a patient with a Mycobacterium abscess: a case report and step-by-step diagnostic approach. Acta clinica Belgica 76 (5) (2020)
Marijke Peetermans, Severien Meyers, Laurens Liesenborghs, Karen Vanhoorelbeke, Simon F De Meyer, Christophe Vandenbriele, Marleen Lox, Marc F Hoylaerts, Kimberly Martinod, Marc Jacquemin, Thomas Vanassche, Peter Verhamme
Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis. Journal of thrombosis and haemostasis : JTH 18 (3) (2019)
Stefano Mancini, Frank Oechslin, Carmen Menzi, Yok Ai Que, Jorien Claes, Ruth Heying, Tiago Rafael Veloso, Thomas Vanassche, Dominique Missiakas, Olaf Schneewind, Philippe Moreillon, José Manuel Entenza
Marginal role of von Willebrand factor-binding protein and coagulase in the initiation of endocarditis in rats with catheter-induced aortic vegetations. Virulence 9 (1) (2019)
L Liesenborghs, P Verhamme, Thomas Vanassche
Staphylococcus aureus, master manipulator of the human hemostatic system. Journal of thrombosis and haemostasis : JTH 16 (3) (2018)